The most common ocular surface disease (OSD) associated with atopic dermatitis (AD) is conjunctivitis, and its occurrence may increase with the use of monoclonal antibody biologics that target the type 2 inflammatory pathway. The purpose of this review is to bring attention to the presence of coexisting OSD in AD patients, with a focus on conjunctivitis, and to equip dermatologists with the knowledge to address mild eye-related concerns.
Read more at the Journal of the American Academy of Dermatology.